Manufacturer record
Macleods Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Macleods Pharmaceuticals Ltd (Daman & Diu) were declared Not of Standard Quality between October 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
15 records linked to Macleods Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ferrous Ascorbate, Folic Acid and Cyanocobalamin Suspension | 18260226AMfg 2026-01 · Exp 2028-12 | Identity test negative for Folic Acid & content of Elemental IronOther | Lucknow LabState lab | Jul 2026 |
| Ferrous Assorbate, Folic Acid and Cyanocobalamin Suspension | 18260226AMfg 2026-01 · Exp 2028-12 | 01. ASSAY OF FOLIC ACID I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Levosalbutamol Sulphate Ambroxol Hydrochloride and Guaiphenesin Expectorant. | 18253692AMfg 2025-09 · Exp 2027-08 | Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder.Description | DTL, Bengaluru, KarnatakaState lab | Jun 2026 |
| Ceftriaxone Injection I.P. | 18251528AMfg 2025-04 · Exp 2027-03 | The sample does not conform to I.P with respect to the tests of Appearance of solution, Clarity of Solution and Particulate MatterParticulate matter | CDL, KolkataCDSCO lab | May 2026 |
| Levosalbutamol Sulphate Ambroxol Hydrochloride and Guaiphenesin Expectorant | 18251296AMfg 2025-03 · Exp 2027-02 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Clobetasol Propionate Neomycin Sulphate and Miconazole Nitrate Cream | 18241408AMfg 2024-07 · Exp 2026-06 | SpouriosOther | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Tranexamic Acid Tablets IP (Trenaxa 500 ) | 18242021AMfg 2024-08 · Exp 2027-07 | Spurious Identification and Assay of Tranexamic AcidAssay | CDL, KolkataCDSCO lab | May 2025 |
| Thyroxine Sodium tablets IP (THYROX-25) | 16240148DMfg 2024-05 · Exp 2026-04 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2024 |
| Glucosamine Sulfate Potassium Chloride MSM and Diacerein Tablets (Orcerin GM ) | KOO2207AMfg 2022-05 · Exp 2025-04 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2024 |
| Deflazacort Tablets ( Defcort 6 Tablets) | GDB23041AMfg 2023-05 · Exp 2026-04 | Test of Identification and Assay of DeflazacortAssay | Not applicableState lab | Aug 2024 |
| Thyroxine Sodium Tablets I.P. (THYROX- 75) | MTC2338AMfg 2023-04 · Exp 2025-03 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2024 |
| Acenomac 1 (Nicoumalone Tablets IP) | FNU02202AMfg 2022-11 · Exp 2024-10 | Related substancesRelated substances | CDL KolkataCDSCO lab | Jun 2023 |
| Calcitriol and Calcium Capsules (BIO-D3 PLUS CAPSULES) | ACB2008AMfg 2020-09 · Exp 2023-08 | Assay of CalcitriolAssay | RDTL ChandigarhState lab | Mar 2022 |
| Cycloserine Capsules USP 250 mg | ECB5836AMfg 2018-07 · Exp 2021-06 | Condensation Products and AssayAssay | CDTL MumbaiCDSCO lab | Nov 2019 |
| Clobetasol Propionate, Neomycin Sulphate and Miconazole Nitrate Cream (PANDERM ++CREAM) | PCF901AMfg 2019-02 · Exp 2021-01 | IdentificationIdentification | RDTL ChandigarhState lab | Oct 2019 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.